pah-europe

PHA Europe (The European Pulmonary Hypertension Association)

An umbrella patient association made up of national PH associations from across Europe. On this site, you will find information about PH, new research, current events, projects, activities and additional resources about livingwell with PH. It also includes a directory of European patient associations to enable you to find your local patient association and peer support networks.

Link tohttps://www.phaeurope.org

PAH Patient Charter

The PAH Patient Charter

The PAH Patient Charter sets out the standards people living with PAH should reasonably expect from their care. The PAH Patient Charter is based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) international guidelines and was developed by Janssen in collaboration with a multidisciplinary group of PAH specialists and PAH patient group representatives.

المراجع

Ysrraelit MC, Fiol MP, Gaitán MI, Correale J. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists. Front Neurol. 2018; 8: 729. Published 2018 Jan 11.doi:10.3389/fneur.2017.00729.
Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017; 11: 1789-1796. Published 2017 Oct 19. doi:10.2147/PPA.S142373.
Parker LS, Topcu G, De Boos D, et al. (2020). The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis.
Green R, Cutter G, Friendly M, et al. Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? Multiple Scler J Exp Transl Clin. 2017; 3(3): 1–6.
de Sa JC, Airas L, Bartholome E, et al. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord. 2011; 4(3): 139-168. doi:10.1177/1756285611403646.
National MS Society/ Symptoms and Diagnosis/MS Symptoms. Accessed June 29, 2020. https://www.nationalmssociety.... Symptoms and Diagnosis/MS Symptoms.
Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017; 11: 1789-1796. Published 2017 Oct 19. doi:10.2147/PPA.S142373.
Green R, Cutter G, Friendly M, et al. Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? Multiple Scler J Exp Transl Clin. 2017; 3(3): 1–6.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson